SEI Investments
SMMT icon

SEI Investments’s Summit Therapeutics SMMT Stock Holding History

SEI Investments’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
44,097
+24,416
+124% +$433K ﹤0.01% 2531
2026
Q1 		$373K Buy
19,681
+9,618
+96% +$156K ﹤0.01% 2755
2025
Q4 		$176K Sell
10,063
-17,100
-63% -$322K ﹤0.01% 2929
2025
Q3 		$561K Buy
27,163
+860
+3% +$20.9K ﹤0.01% 2179
2025
Q2 		$560K Buy
+26,303
New +$600K ﹤0.01% 2135
2024
Q3 		– Sell
-10,396
Closed -$81.1K – 2754
2024
Q2 		$81.1K Hold
10,396
– – ﹤0.01% 2548
2024
Q1 		$43K Hold
10,396
– – ﹤0.01% 2576
2023
Q4 		$27.1K Hold
10,396
– – ﹤0.01% 2585
2023
Q3 		$19.4K Hold
10,396
– – ﹤0.01% 2605
2023
Q2 		$26.1K Buy
+10,396
New +$19K ﹤0.01% 2644

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SEI Investments's SMMT Position: Q2 2026 in Review

SEI Investments increased its Summit Therapeutics (SMMT) stake by 124% in Q2 2026, buying an estimated $433K and bringing the position to 44,097 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #2531.

SEI Investments first reported a position in SMMT in Q2 2023 and has held it in 10 quarters since. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • SEI Investments held 44,097 shares of Summit Therapeutics worth $642K as of Q2 2026.
  • SEI Investments bought 24,416 Summit Therapeutics shares in Q2 2026, an estimated $433K.
  • Summit Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2531 holding.
  • SEI Investments first reported a position in Summit Therapeutics in Q2 2023 and has held it in 10 quarters since.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.